Aier Eye Hospital invests 1 bn yuan in wealth management for capital optimization

Aier Eye Hospital Group has implemented its cash management strategy, utilizing 1 billion yuan of idle self-owned funds to purchase a wealth management product. This move follows the approval by its board and supervisory board on March 24, 2025, to manage up to 1.5 billion yuan of idle funds in low-risk, highly liquid financial products for 12 months.

The specific product acquired is the "CITIC Securities Wealth Private Investment Aier No. 1 FOF Single Asset Management Plan," rated "low to medium risk." The investment, amounting to 100,000,000 yuan, has a performance benchmark of 4%. Interest accrual began on September 22, 2025, with flexible redemption options. This investment aims to enhance capital efficiency and secure additional returns for the company and its shareholders, without impacting daily operations or capital security.

Aier Eye Hospital Group emphasizes strict adherence to prudent investment principles, focusing on low-risk options and prohibiting investments in stocks or unsecured debt. Internal controls include continuous monitoring by the financial center, regular audits by the internal audit department, and oversight by the supervisory board and independent directors to manage investment risks effectively.